The purpose of this study is to identify the abnormalities of bronchial trans-epithelial transport of chloride, sodium and bicarbonate in patients with idiopathic dilations of the bronchi.
Dilations of the bronchi happens for one child over 3000. The extended forms may progress to respiratory failure. More than one case over two remains of undetermined cause. If the prototype is the cystic fibrosis, other abnormalities of ionic transport may be the cause of a failure of mucociliary clearance and enhance the idiopathic dilations of the bronchi. The purpose of this study is to identify the abnormalities of bronchial trans-epithelial transport of chloride, sodium and bicarbonate in patients with idiopathic dilations of the bronchi, in comparison to two others groups of patients (without abnormality of ionic transport/with typical cystic fibrosis).
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
42
bronchial ddp test during endoscopy, nasal smear, bronchial smear
Necker-Enfants Malades Hospital
Paris, France
Response to isoproterenol in solution without chloride ions during bronchial potential difference test (ΔIsoprotérénol / bronchial).
Difference between groups for Level of repolarisation
Time frame: up to 5 days
Response to amiloride during bronchial potential difference test
Trans-epithelial transport measured in vivo
Time frame: up to 5 days
trans-epithelial ionic transport in the nasal epithelium (nasal DDP)
Trans-epithelial transport measured in vivo
Time frame: up to 5 days
trans-epithelial ionic transport of sweat epithelium (sweat test)
Trans-epithelial transport measured in vivo
Time frame: up to 5 days
Basal current short circuit
Trans-bronchial epithelial ionic transport evaluated in vitro on bronchial primary cultures
Time frame: up to 5 days
Response to Epithelial Sodium Channel (ENaC) inhibitors
Trans-bronchial epithelial ionic transport evaluated in vitro on bronchial primary cultures
Time frame: up to 5 days
Activation of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)
Trans-bronchial epithelial ionic transport evaluated in vitro on bronchial primary cultures
Time frame: up to 5 days
Inhibition of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) (inh-172)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Trans-bronchial epithelial ionic transport evaluated in vitro on bronchial primary cultures
Time frame: up to 5 days
Activation of Calcium (Ca)-dependent Chloride (Cl-) ion channels
Trans-bronchial epithelial ionic transport evaluated in vitro on bronchial primary cultures
Time frame: up to 5 days
Inhibition of Solute Carrier family 26, member 9 (SLC26A9)
Trans-bronchial epithelial ionic transport evaluated in vitro on bronchial primary cultures
Time frame: up to 5 days
Response to inhibitors of potassium (K+ ) secretion basolateral
Trans-bronchial epithelial ionic transport evaluated in vitro on bronchial primary cultures
Time frame: up to 5 days
Bicarbonate (HCO3- ) secretion in response to forskolin
Trans-bronchial epithelial ionic transport evaluated in vitro on bronchial primary cultures
Time frame: up to 5 days